These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11741345

  • 1. Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data.
    Lauta VM.
    Cytokine; 2001 Nov 07; 16(3):79-86. PubMed ID: 11741345
    [Abstract] [Full Text] [Related]

  • 2. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM.
    Cancer; 2003 May 15; 97(10):2440-52. PubMed ID: 12733143
    [Abstract] [Full Text] [Related]

  • 3. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2000 Sep 15; 11(3):443-51. PubMed ID: 11022130
    [Abstract] [Full Text] [Related]

  • 4. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X, Blade J, Guillermo AL, Molina R, Rozman C, Ballesta AM.
    Cancer Detect Prev; 1996 Sep 15; 20(1):52-6. PubMed ID: 8907203
    [Abstract] [Full Text] [Related]

  • 5. Serum Levels of Interleukin-8 and Soluble Interleukin-6 Receptor in Patients with Stage-I Multiple Myeloma: A Case-Control Study.
    Kohsari M, Khadem-Ansari MH, Rasmi Y, Sayyadi H.
    Asian Pac J Cancer Prev; 2020 Jan 01; 21(1):127-132. PubMed ID: 31983174
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity.
    Papadaki H, Kyriakou D, Foudoulakis A, Markidou F, Alexandrakis M, Eliopoulos GD.
    Acta Haematol; 1997 Jan 01; 97(4):191-5. PubMed ID: 9158660
    [Abstract] [Full Text] [Related]

  • 7. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.
    Barillé S, Bataille R, Amiot M.
    Eur Cytokine Netw; 2000 Dec 01; 11(4):546-51. PubMed ID: 11125296
    [Abstract] [Full Text] [Related]

  • 8. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
    Kovacs E.
    Biomed Pharmacother; 2003 Dec 01; 57(10):489-94. PubMed ID: 14637393
    [Abstract] [Full Text] [Related]

  • 9. The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.
    Tsirakis G, Pappa CA, Kaparou M, Boula A, Katsomitrou V, Xekalou A, Kyriakaki S, Alexandrakis MG.
    Tumour Biol; 2013 Apr 01; 34(2):859-64. PubMed ID: 23242610
    [Abstract] [Full Text] [Related]

  • 10. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A, Urbańska-Ryś H, Robak T.
    Br J Haematol; 1999 May 01; 105(2):412-9. PubMed ID: 10233412
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J.
    Clin Exp Rheumatol; 2003 May 01; 21(1):63-9. PubMed ID: 12673891
    [Abstract] [Full Text] [Related]

  • 12. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy.
    Gaillard JP, Bataille R, Brailly H, Zuber C, Yasukawa K, Attal M, Maruo N, Taga T, Kishimoto T, Klein B.
    Eur J Immunol; 1993 Apr 01; 23(4):820-4. PubMed ID: 8458373
    [Abstract] [Full Text] [Related]

  • 13. Incidence of apoptosis and cell proliferation in multiple myeloma: correlation with bcl-2 protein expression and serum levels of interleukin-6 (IL-6) and soluble IL-6 receptor.
    Chaidos AI, Bai MC, Kamina SA, Kanavaros PE, Agnantis NJ, Bourantas KL.
    Eur J Haematol; 2002 Aug 01; 69(2):90-4. PubMed ID: 12366711
    [Abstract] [Full Text] [Related]

  • 14. The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma.
    Stasi R, Brunetti M, Parma A, Di Giulio C, Terzoli E, Pagano A.
    Cancer; 1998 May 15; 82(10):1860-6. PubMed ID: 9587117
    [Abstract] [Full Text] [Related]

  • 15. Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells in multiple myeloma: potential for autocrine and paracrine networks.
    Szczepek AJ, Belch AR, Pilarski LM.
    Exp Hematol; 2001 Sep 15; 29(9):1076-81. PubMed ID: 11532348
    [Abstract] [Full Text] [Related]

  • 16. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
    Gaillard JP, Liautard J, Klein B, Brochier J.
    Eur J Immunol; 1997 Dec 15; 27(12):3332-40. PubMed ID: 9464821
    [Abstract] [Full Text] [Related]

  • 17. [Soluble interleukin-6 receptors in the serum in multiple myeloma].
    Scudla V, Kubalová D, Bacovský J, Lukes J, Vavrdová V.
    Cas Lek Cesk; 1996 Nov 20; 135(22):719-22. PubMed ID: 8998823
    [Abstract] [Full Text] [Related]

  • 18. [Clinical significance of soluble interleukin-2 receptor in multiple myeloma].
    Akimoto Y, Ishiyama T, Ueno H, Hino K, Tomoyasu S, Tsuruoka N.
    Rinsho Ketsueki; 1995 Nov 20; 36(11):1247-51. PubMed ID: 8691563
    [Abstract] [Full Text] [Related]

  • 19. Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor.
    Hargreaves PG, Wang F, Antcliff J, Murphy G, Lawry J, Russell RG, Croucher PI.
    Br J Haematol; 1998 Jun 20; 101(4):694-702. PubMed ID: 9674743
    [Abstract] [Full Text] [Related]

  • 20. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group.
    Pulkki K, Pelliniemi TT, Rajamäki A, Tienhaara A, Laakso M, Lahtinen R.
    Br J Haematol; 1996 Feb 20; 92(2):370-4. PubMed ID: 8603002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.